Current research primarily focused on the detection of Reg3A and Reg4 levels in serum and tumor tissues, with superior accuracy and sensitivity compared to the existing biomarkers, making them promising novel indicators for both diagnosis and prognosis [78,79]. This evidence concerns the gene REG3A and neoplasm.